Mariusz Kowalewski
Overview
Explore the profile of Mariusz Kowalewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
175
Citations
1601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Urbanowicz T, Hanc A, Frackowiak J, Bialasik-Misiorny M, Radek Z, Krama M, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274472
: Multiple risk factors for coronary artery disease have been identified without answering one of the leading questions related to the extent of the involvement of the epicardial arteries. Trace...
12.
Aerts L, Kawczynski M, Bidar E, Luermans J, Chaldoupi S, La Meir M, et al.
Europace
. 2024 Sep;
26(10).
PMID: 39255332
Aims: Both isolated thoracoscopic and hybrid thoracoscopic atrial fibrillation (AF) ablation techniques have demonstrated favourable outcomes in the management of patients with (long-standing) persistent AF, as compared with catheter ablation....
13.
Urbanowicz T, Skotak K, Krasinska-Plachta A, Kowalewski M, Olasinska-Wisniewska A, Szczepanski K, et al.
Medicina (Kaunas)
. 2024 Aug;
60(8).
PMID: 39202607
: There is mounting evidence that diabetic-related cardiac metabolism abnormalities with oxidative stress and inflammatory mechanism activation align with the functional impairments that result in atherosclerotic lesion formation. Among the...
14.
Urbanowicz T, Hanc A, Frackowiak J, Bialasik-Misiorny M, Olasinska-Wisniewska A, Krasinska B, et al.
Biol Trace Elem Res
. 2024 Aug;
PMID: 39145863
Coronary artery disease is among the leading current epidemiological challenges. The genetic, clinical, and lifestyle-related risk factors are well documented. The reason for specific epicardial artery locations remains unsolved. The...
15.
Pasierski M, Batko J, Suwalski P, Kowalewski M
Eur J Cardiothorac Surg
. 2024 Aug;
66(3).
PMID: 39133166
No abstract available.
16.
Niezgoda P, Kasprzak M, Kubica J, Kuzma L, Januszek R, Iwanczyk S, et al.
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124731
: The rate of in-stent restenosis (ISR) is decreasing; however, it is still a challenge for contemporary invasive cardiologists. Therapeutic methods, including drug-eluting balloons (DEBs), intravascular lithotripsy, excimer laser coronary...
17.
Koslinski P, Rzepinski L, Koba M, Maciejek Z, Kowalewski M, Daghir-Wojtkowiak E
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064122
: Multiple sclerosis (MS) and myasthenia gravis (MG) are autoimmune diseases that attack the central nervous system (CNS) and the neuromuscular junction, respectively. As the common pathogenesis of both diseases...
18.
Meani P, Todaro S, Veronese G, Kowalewski M, Montisci A, Protti I, et al.
Perfusion
. 2024 Jul;
:2676591241268389.
PMID: 39058419
The concept of left ventricular unloading has its foundation in heart physiology. In fact, the left ventricular mechanics and energetics represent the cornerstone of this approach. The novel sophisticated therapies...
19.
Wanha W, Iwanczyk S, Januszek R, Wolny R, Tomasiewicz B, Kuliczkowski W, et al.
Circ Cardiovasc Interv
. 2024 Jul;
17(9):e014064.
PMID: 39051094
Background: Evidence suggests that drug-coated balloons may benefit in-stent restenosis (ISR) treatment. However, the efficacy of new-generation sirolimus-coated balloon (SCB) compared with the latest generation drug-eluting stents (DESs) has not...
20.
Kowalewski M, Swieczkowski M, Kuzma L, Maesen B, Dabrowski E, Matteucci M, et al.
JTCVS Open
. 2024 Jul;
19:131-163.
PMID: 39015454
Objective: Left atrial appendage closure (LAAC) concomitant to heart surgery in patients with underlying atrial fibrillation (AF) has gained attention because of long-term reduction of thromboembolic complications. As of mortality...